Changes in Buprenorphine Visits in Frontier and Remote Locations: Effects of the SARS-COV-2 Pandemic

View Resource

Evaluated patient appointments offering buprenorphine prescriptions in the 55 weeks before and after the start of the COVID-19 pandemic to determine the impact of the pandemic and pandemic-era policies on buprenorphine access for frontier residents in the Great Plains region.

Lisa M. McFadden

Drug and Alcohol Dependence Reports, 7, 100155

06/2023

Document

Access · COVID-19 · Frontier and remote areas · Illicit drug use · Policy · Prescription drug misuse · Statistics and data